Hormonal Contraceptive Market 2027 By Method, Hormones, End User | The Insight Partners

Hormonal Contraceptive Market to 2027 - Global Analysis and Forecasts by Method (Combined Oral Contraceptives, Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, Transdermal Patch, Vaginal Ring); Hormones (Androgens, Estrogens, Progestogens, Gonadotropins, Antiandrogens, Others); End User (Hospitals, Homecare, Gynecology Centers, Clinics, Ambulatory Surgical Centers)

Report Code: TIPRE00004959 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Hormonal Contraceptive are one of the birth control methods that act on the endocrine system of the female to prevent ovulation and avoid fertilization. These also change the uterus, making it unlikely to develop pregnancy.

MARKET DYNAMICS
The Hormonal Contraceptive market is anticipated to grow in the forecast, owing to the factors such as urbanization, increasing family planning, increasing user awareness, rise in menstruating population, and encouragement of government to use contraceptives.

MARKET SCOPE
The "Global Hormonal Contraceptive Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hormonal Contraceptive market with detailed market segmentation by Drugs and geography. The global Hormonal Contraceptive market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Hormonal Contraceptive market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Hormonal Contraceptive market is segmented on the basis of Method, Hormones and End User. Based on Method the market is segmented into Combined Oral Contraceptives, Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, Transdermal Patch, and Vaginal Ring. Based on Hormones the market is segmented into Androgens, Estrogens, Progestogens, Gonadotropins, Antiandrogens, Others. Based on End User the market is segmented into Hospitals, Homecare, Gynecology Centers, Clinics, and Ambulatory Surgical Centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Hormonal Contraceptive market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hormonal Contraceptive market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Hormonal Contraceptive market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hormonal Contraceptive market in these regions.

MARKET PLAYERS
The reports cover key developments in the Hormonal Contraceptive market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Hormonal Contraceptive market are anticipated to lucrative growth opportunities in the future with the rising demand for Hormonal Contraceptive market in the global market. Below mentioned is the list of few companies engaged in the Hormonal Contraceptive market.

The report also includes the profiles of Hormonal Contraceptive market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Amgen
  • Bayer Healthcare Pharmaceuticals
  • Cipla Limited
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals, Inc
  • Novartis AG
  • Pfizer, Inc
  • Piramal Healthcare Limited
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hormonal Contraceptive Market - By Method
1.3.2 Hormonal Contraceptive Market - By Hormones
1.3.3 Hormonal Contraceptive Market - By End User
1.3.4 Hormonal Contraceptive Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HORMONAL CONTRACEPTIVE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HORMONAL CONTRACEPTIVE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HORMONAL CONTRACEPTIVE MARKET - GLOBAL MARKET ANALYSIS
6.1. HORMONAL CONTRACEPTIVE - GLOBAL MARKET OVERVIEW
6.2. HORMONAL CONTRACEPTIVE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HORMONAL CONTRACEPTIVE MARKET - REVENUE AND FORECASTS TO 2027 - METHOD
7.1. OVERVIEW
7.2. METHOD MARKET FORECASTS AND ANALYSIS
7.3. COMBINED ORAL CONTRACEPTIVES
7.3.1. Overview
7.3.2. Combined Oral Contraceptives Market Forecast and Analysis
7.4. ORAL CONTRACEPTIVES
7.4.1. Overview
7.4.2. Oral Contraceptives Market Forecast and Analysis
7.5. IMPLANTED CONTRACEPTIVES
7.5.1. Overview
7.5.2. Implanted Contraceptives Market Forecast and Analysis
7.6. INJECTED CONTRACEPTIVES
7.6.1. Overview
7.6.2. Injected Contraceptives Market Forecast and Analysis
7.7. INTRAUTERINE
7.7.1. Overview
7.7.2. Intrauterine Market Forecast and Analysis
7.8. TRANSDERMAL PATCH
7.8.1. Overview
7.8.2. Transdermal Patch Market Forecast and Analysis
7.9. VAGINAL RING
7.9.1. Overview
7.9.2. Vaginal Ring Market Forecast and Analysis
8. HORMONAL CONTRACEPTIVE MARKET - REVENUE AND FORECASTS TO 2027 - HORMONES
8.1. OVERVIEW
8.2. HORMONES MARKET FORECASTS AND ANALYSIS
8.3. ANDROGENS
8.3.1. Overview
8.3.2. Androgens Market Forecast and Analysis
8.4. ESTROGENS
8.4.1. Overview
8.4.2. Estrogens Market Forecast and Analysis
8.5. PROGESTOGENS
8.5.1. Overview
8.5.2. Progestogens Market Forecast and Analysis
8.6. GONADOTROPINS
8.6.1. Overview
8.6.2. Gonadotropins Market Forecast and Analysis
8.7. ANTIANDROGENS
8.7.1. Overview
8.7.2. Antiandrogens Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. HORMONAL CONTRACEPTIVE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. HOMECARE
9.4.1. Overview
9.4.2. Homecare Market Forecast and Analysis
9.5. GYNECOLOGY CENTERS
9.5.1. Overview
9.5.2. Gynecology Centers Market Forecast and Analysis
9.6. CLINICS
9.6.1. Overview
9.6.2. Clinics Market Forecast and Analysis
9.7. AMBULATORY SURGICAL CENTERS
9.7.1. Overview
9.7.2. Ambulatory Surgical Centers Market Forecast and Analysis
10. HORMONAL CONTRACEPTIVE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Hormonal Contraceptive Market Overview
10.1.2 North America Hormonal Contraceptive Market Forecasts and Analysis
10.1.3 North America Hormonal Contraceptive Market Forecasts and Analysis - By Method
10.1.4 North America Hormonal Contraceptive Market Forecasts and Analysis - By Hormones
10.1.5 North America Hormonal Contraceptive Market Forecasts and Analysis - By End User
10.1.6 North America Hormonal Contraceptive Market Forecasts and Analysis - By Countries
10.1.6.1 United States Hormonal Contraceptive Market
10.1.6.1.1 United States Hormonal Contraceptive Market by Method
10.1.6.1.2 United States Hormonal Contraceptive Market by Hormones
10.1.6.1.3 United States Hormonal Contraceptive Market by End User
10.1.6.2 Canada Hormonal Contraceptive Market
10.1.6.2.1 Canada Hormonal Contraceptive Market by Method
10.1.6.2.2 Canada Hormonal Contraceptive Market by Hormones
10.1.6.2.3 Canada Hormonal Contraceptive Market by End User
10.1.6.3 Mexico Hormonal Contraceptive Market
10.1.6.3.1 Mexico Hormonal Contraceptive Market by Method
10.1.6.3.2 Mexico Hormonal Contraceptive Market by Hormones
10.1.6.3.3 Mexico Hormonal Contraceptive Market by End User
10.1.6.4 US Hormonal Contraceptive Market
10.1.6.4.1 US Hormonal Contraceptive Market by Method
10.1.6.4.2 US Hormonal Contraceptive Market by Hormones
10.1.6.4.3 US Hormonal Contraceptive Market by End User
10.2. EUROPE
10.2.1 Europe Hormonal Contraceptive Market Overview
10.2.2 Europe Hormonal Contraceptive Market Forecasts and Analysis
10.2.3 Europe Hormonal Contraceptive Market Forecasts and Analysis - By Method
10.2.4 Europe Hormonal Contraceptive Market Forecasts and Analysis - By Hormones
10.2.5 Europe Hormonal Contraceptive Market Forecasts and Analysis - By End User
10.2.6 Europe Hormonal Contraceptive Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Hormonal Contraceptive Market
10.2.6.1.1 Germany Hormonal Contraceptive Market by Method
10.2.6.1.2 Germany Hormonal Contraceptive Market by Hormones
10.2.6.1.3 Germany Hormonal Contraceptive Market by End User
10.2.6.2 France Hormonal Contraceptive Market
10.2.6.2.1 France Hormonal Contraceptive Market by Method
10.2.6.2.2 France Hormonal Contraceptive Market by Hormones
10.2.6.2.3 France Hormonal Contraceptive Market by End User
10.2.6.3 Italy Hormonal Contraceptive Market
10.2.6.3.1 Italy Hormonal Contraceptive Market by Method
10.2.6.3.2 Italy Hormonal Contraceptive Market by Hormones
10.2.6.3.3 Italy Hormonal Contraceptive Market by End User
10.2.6.4 Spain Hormonal Contraceptive Market
10.2.6.4.1 Spain Hormonal Contraceptive Market by Method
10.2.6.4.2 Spain Hormonal Contraceptive Market by Hormones
10.2.6.4.3 Spain Hormonal Contraceptive Market by End User
10.2.6.5 United Kingdom Hormonal Contraceptive Market
10.2.6.5.1 United Kingdom Hormonal Contraceptive Market by Method
10.2.6.5.2 United Kingdom Hormonal Contraceptive Market by Hormones
10.2.6.5.3 United Kingdom Hormonal Contraceptive Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Hormonal Contraceptive Market Overview
10.3.2 Asia-Pacific Hormonal Contraceptive Market Forecasts and Analysis
10.3.3 Asia-Pacific Hormonal Contraceptive Market Forecasts and Analysis - By Method
10.3.4 Asia-Pacific Hormonal Contraceptive Market Forecasts and Analysis - By Hormones
10.3.5 Asia-Pacific Hormonal Contraceptive Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Hormonal Contraceptive Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Hormonal Contraceptive Market
10.3.6.1.1 Australia Hormonal Contraceptive Market by Method
10.3.6.1.2 Australia Hormonal Contraceptive Market by Hormones
10.3.6.1.3 Australia Hormonal Contraceptive Market by End User
10.3.6.2 China Hormonal Contraceptive Market
10.3.6.2.1 China Hormonal Contraceptive Market by Method
10.3.6.2.2 China Hormonal Contraceptive Market by Hormones
10.3.6.2.3 China Hormonal Contraceptive Market by End User
10.3.6.3 India Hormonal Contraceptive Market
10.3.6.3.1 India Hormonal Contraceptive Market by Method
10.3.6.3.2 India Hormonal Contraceptive Market by Hormones
10.3.6.3.3 India Hormonal Contraceptive Market by End User
10.3.6.4 Japan Hormonal Contraceptive Market
10.3.6.4.1 Japan Hormonal Contraceptive Market by Method
10.3.6.4.2 Japan Hormonal Contraceptive Market by Hormones
10.3.6.4.3 Japan Hormonal Contraceptive Market by End User
10.3.6.5 South Korea Hormonal Contraceptive Market
10.3.6.5.1 South Korea Hormonal Contraceptive Market by Method
10.3.6.5.2 South Korea Hormonal Contraceptive Market by Hormones
10.3.6.5.3 South Korea Hormonal Contraceptive Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Hormonal Contraceptive Market Overview
10.4.2 Middle East and Africa Hormonal Contraceptive Market Forecasts and Analysis
10.4.3 Middle East and Africa Hormonal Contraceptive Market Forecasts and Analysis - By Method
10.4.4 Middle East and Africa Hormonal Contraceptive Market Forecasts and Analysis - By Hormones
10.4.5 Middle East and Africa Hormonal Contraceptive Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Hormonal Contraceptive Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Hormonal Contraceptive Market
10.4.6.1.1 South Africa Hormonal Contraceptive Market by Method
10.4.6.1.2 South Africa Hormonal Contraceptive Market by Hormones
10.4.6.1.3 South Africa Hormonal Contraceptive Market by End User
10.4.6.2 Saudi Arabia Hormonal Contraceptive Market
10.4.6.2.1 Saudi Arabia Hormonal Contraceptive Market by Method
10.4.6.2.2 Saudi Arabia Hormonal Contraceptive Market by Hormones
10.4.6.2.3 Saudi Arabia Hormonal Contraceptive Market by End User
10.4.6.3 U.A.E Hormonal Contraceptive Market
10.4.6.3.1 U.A.E Hormonal Contraceptive Market by Method
10.4.6.3.2 U.A.E Hormonal Contraceptive Market by Hormones
10.4.6.3.3 U.A.E Hormonal Contraceptive Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Hormonal Contraceptive Market Overview
10.5.2 South and Central America Hormonal Contraceptive Market Forecasts and Analysis
10.5.3 South and Central America Hormonal Contraceptive Market Forecasts and Analysis - By Method
10.5.4 South and Central America Hormonal Contraceptive Market Forecasts and Analysis - By Hormones
10.5.5 South and Central America Hormonal Contraceptive Market Forecasts and Analysis - By End User
10.5.6 South and Central America Hormonal Contraceptive Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Hormonal Contraceptive Market
10.5.6.1.1 Brazil Hormonal Contraceptive Market by Method
10.5.6.1.2 Brazil Hormonal Contraceptive Market by Hormones
10.5.6.1.3 Brazil Hormonal Contraceptive Market by End User
10.5.6.2 Argentina Hormonal Contraceptive Market
10.5.6.2.1 Argentina Hormonal Contraceptive Market by Method
10.5.6.2.2 Argentina Hormonal Contraceptive Market by Hormones
10.5.6.2.3 Argentina Hormonal Contraceptive Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HORMONAL CONTRACEPTIVE MARKET, KEY COMPANY PROFILES
12.1. AMGEN
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BAYER HEALTHCARE PHARMACEUTICALS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CIPLA LIMITED
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLENMARK PHARMACEUTICALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. LUPIN PHARMACEUTICALS, INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NOVARTIS AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER, INC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PIRAMAL HEALTHCARE LIMITED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SUN PHARMACEUTICAL INDUSTRIES LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

- Amgen
- Bayer Healthcare Pharmaceuticals
- Cipla Limited
- Glenmark Pharmaceuticals
- Lupin Pharmaceuticals, Inc
- Novartis AG
- Pfizer, Inc
- Piramal Healthcare Limited
- Sun Pharmaceutical Industries Ltd
- Teva Pharmaceutical Industries